Prostate cancer is one of the most common cancers among men, with early detection being crucial for successful treatment. NucleoBio, a cutting-edge biotech company, has developed a revolutionary blood-based test that aims to change the landscape of prostate cancer diagnosis. This groundbreaking test offers precision diagnosis, empowering physicians to tailor personalized interventions for their patients. Traditionally, prostate cancer diagnosis involved invasive procedures th